Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 9:30 AM ESTCompany ParticipantsAaron ...

Unprecedented Phase 1 CML efficacy data and potential best-in-disease profile of TERN-701 featured in ASH 2025 abstract Upcoming ASH oral ...

Researchers from the Department of Molecular Physics at the Fritz Haber Institute have demonstrated the first magneto-optical trap of a stable "closed-shell" molecule: aluminum monofluoride (AlF).

Bristol, England–based EnsiliTech has developed technology that keeps protein molecules such as vaccines, antibodies, and ...

SEP-479 Selected as Next-Generation Oral PTH1R Agonist Development CandidateSEP-631 (MRGPRX2 NAM) Phase 1 Clinical Trial in Healthy Volunteers ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Astronomers have discovered phosphine gas in the atmosphere of an ancient brown dwarf, Wolf 1130C, using the James Webb Space ...

Watson co-discover the double-helix structure of DNA, but his reputation was later damaged by his comments on race and sex.

Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules ...

The 72-week multinational phase 3 ATTAIN-2 trial randomized 1613 participants with obesity or overweight (BMI ≥ 27.0) and T2D ...

Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...